Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Outcome | 8 | 2014 | 157 | 0.700 |
Why?
|
| Pregnancy | 40 | 2019 | 2334 | 0.550 |
Why?
|
| Premature Birth | 5 | 2012 | 150 | 0.470 |
Why?
|
| Labor Presentation | 3 | 1999 | 8 | 0.370 |
Why?
|
| Cerclage, Cervical | 1 | 2009 | 11 | 0.340 |
Why?
|
| Fetal Membranes, Premature Rupture | 5 | 2012 | 45 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2013 | 92 | 0.330 |
Why?
|
| Specimen Handling | 1 | 2008 | 46 | 0.320 |
Why?
|
| Pregnancy Complications | 5 | 2014 | 286 | 0.310 |
Why?
|
| Medical Errors | 1 | 2008 | 80 | 0.300 |
Why?
|
| Laparoscopy | 1 | 2009 | 237 | 0.290 |
Why?
|
| Amniotic Fluid | 3 | 2006 | 30 | 0.280 |
Why?
|
| Obstetric Labor Complications | 2 | 2013 | 20 | 0.250 |
Why?
|
| Cervix Uteri | 6 | 2008 | 64 | 0.250 |
Why?
|
| Version, Fetal | 3 | 1999 | 8 | 0.230 |
Why?
|
| Postpartum Hemorrhage | 4 | 2014 | 12 | 0.230 |
Why?
|
| Infant, Newborn | 18 | 2014 | 2455 | 0.220 |
Why?
|
| Obstetric Labor, Premature | 6 | 2002 | 76 | 0.210 |
Why?
|
| Delivery, Obstetric | 4 | 2014 | 58 | 0.210 |
Why?
|
| Hospitals | 2 | 2014 | 265 | 0.190 |
Why?
|
| Pre-Eclampsia | 5 | 2010 | 202 | 0.190 |
Why?
|
| Female | 40 | 2019 | 38021 | 0.180 |
Why?
|
| Vagina | 3 | 2012 | 87 | 0.170 |
Why?
|
| Adult | 24 | 2019 | 21379 | 0.160 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 81 | 0.160 |
Why?
|
| Parity | 3 | 2012 | 71 | 0.150 |
Why?
|
| Breech Presentation | 4 | 1999 | 11 | 0.150 |
Why?
|
| Gestational Age | 7 | 2005 | 389 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2019 | 191 | 0.140 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1996 | 1 | 0.140 |
Why?
|
| Infant, Premature | 5 | 2012 | 284 | 0.140 |
Why?
|
| Humans | 41 | 2019 | 68549 | 0.130 |
Why?
|
| Puerperal Infection | 2 | 2013 | 15 | 0.130 |
Why?
|
| Pyelonephritis | 2 | 1987 | 17 | 0.130 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 694 | 0.120 |
Why?
|
| Maternal Health Services | 1 | 2014 | 22 | 0.120 |
Why?
|
| Hospitalization | 2 | 2011 | 977 | 0.120 |
Why?
|
| Heart Rate, Fetal | 1 | 2013 | 12 | 0.110 |
Why?
|
| Fibronectins | 4 | 2008 | 130 | 0.110 |
Why?
|
| Fetal Monitoring | 1 | 2013 | 20 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2013 | 49 | 0.110 |
Why?
|
| Cervical Length Measurement | 1 | 2012 | 2 | 0.110 |
Why?
|
| Hydroxyprogesterones | 1 | 2012 | 6 | 0.110 |
Why?
|
| Progestins | 1 | 2012 | 19 | 0.110 |
Why?
|
| Prospective Studies | 7 | 2009 | 3703 | 0.110 |
Why?
|
| Cesarean Section | 5 | 1999 | 101 | 0.110 |
Why?
|
| Young Adult | 6 | 2014 | 5710 | 0.100 |
Why?
|
| Recurrence | 3 | 2010 | 948 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 1046 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 13 | 0.100 |
Why?
|
| Obesity | 1 | 2019 | 1074 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 2 | 1981 | 11 | 0.100 |
Why?
|
| Lidocaine | 2 | 1981 | 36 | 0.100 |
Why?
|
| Bradycardia | 2 | 1981 | 45 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2013 | 34 | 0.100 |
Why?
|
| Fetal Diseases | 2 | 1988 | 64 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 2 | 1997 | 85 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2011 | 79 | 0.090 |
Why?
|
| United States | 7 | 2014 | 7338 | 0.090 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2009 | 4 | 0.090 |
Why?
|
| Abortion, Habitual | 1 | 2009 | 13 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 27 | 0.080 |
Why?
|
| Laparotomy | 1 | 2009 | 65 | 0.080 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2009 | 33 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 2 | 1999 | 79 | 0.080 |
Why?
|
| Abdomen | 1 | 2009 | 80 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 180 | 0.080 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2008 | 20 | 0.080 |
Why?
|
| Monosomy | 1 | 1988 | 6 | 0.080 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1988 | 6 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 1988 | 22 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 41 | 0.080 |
Why?
|
| Nitrofurantoin | 1 | 1987 | 6 | 0.080 |
Why?
|
| Fetus | 1 | 2008 | 157 | 0.080 |
Why?
|
| Physical Examination | 1 | 1988 | 152 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 1999 | 69 | 0.070 |
Why?
|
| Smoking | 2 | 2012 | 1449 | 0.070 |
Why?
|
| Bacteriuria | 1 | 1986 | 7 | 0.070 |
Why?
|
| Logistic Models | 5 | 2014 | 1419 | 0.070 |
Why?
|
| Vaginal Diseases | 1 | 2005 | 11 | 0.070 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 19 | 0.070 |
Why?
|
| Bacteriological Techniques | 2 | 1986 | 49 | 0.070 |
Why?
|
| Uterine Hemorrhage | 1 | 2005 | 16 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 56 | 0.060 |
Why?
|
| Bacteria | 1 | 1986 | 193 | 0.060 |
Why?
|
| Fetal Heart | 2 | 1981 | 41 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2005 | 163 | 0.060 |
Why?
|
| Perineum | 2 | 2014 | 11 | 0.060 |
Why?
|
| Lacerations | 2 | 2014 | 13 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2014 | 2356 | 0.060 |
Why?
|
| Labor, Obstetric | 3 | 2013 | 23 | 0.060 |
Why?
|
| Maternal Mortality | 2 | 2014 | 16 | 0.050 |
Why?
|
| Uterine Inertia | 1 | 1982 | 1 | 0.050 |
Why?
|
| Prostaglandins F | 1 | 1982 | 13 | 0.050 |
Why?
|
| Venous Thromboembolism | 2 | 2014 | 117 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2006 | 1026 | 0.050 |
Why?
|
| Ferritins | 1 | 2002 | 49 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 1981 | 14 | 0.050 |
Why?
|
| Terbutaline | 1 | 1981 | 23 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 1981 | 30 | 0.050 |
Why?
|
| Nitrites | 1 | 1981 | 53 | 0.050 |
Why?
|
| Urine | 1 | 1981 | 47 | 0.050 |
Why?
|
| Risk Factors | 6 | 2014 | 5720 | 0.050 |
Why?
|
| Labor, Induced | 2 | 2014 | 18 | 0.050 |
Why?
|
| Anesthesia, Epidural | 1 | 1999 | 11 | 0.040 |
Why?
|
| Random Allocation | 4 | 1987 | 442 | 0.040 |
Why?
|
| Fetal Weight | 1 | 1999 | 33 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 1999 | 37 | 0.040 |
Why?
|
| Infant Mortality | 1 | 1999 | 59 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 1465 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2009 | 7268 | 0.040 |
Why?
|
| Incidence | 3 | 2012 | 1582 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 1999 | 121 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2002 | 39 | 0.040 |
Why?
|
| Adolescent | 5 | 2012 | 8904 | 0.040 |
Why?
|
| Fetal Death | 1 | 1997 | 49 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2019 | 241 | 0.040 |
Why?
|
| Twins | 1 | 1996 | 42 | 0.040 |
Why?
|
| Hypertension | 2 | 2011 | 1533 | 0.040 |
Why?
|
| Pregnancy, Multiple | 1 | 1996 | 32 | 0.030 |
Why?
|
| Suction | 1 | 1996 | 33 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 1996 | 38 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 99 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 631 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 648 | 0.030 |
Why?
|
| Time Factors | 5 | 2009 | 4655 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2005 | 46 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 28 | 0.030 |
Why?
|
| Peripartum Period | 1 | 2013 | 15 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2005 | 1738 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 392 | 0.030 |
Why?
|
| Reproductive Tract Infections | 1 | 2012 | 3 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3256 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2005 | 186 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 880 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 618 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2006 | 929 | 0.020 |
Why?
|
| Uterus | 2 | 1981 | 77 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2014 | 322 | 0.020 |
Why?
|
| Fetal Distress | 2 | 1999 | 8 | 0.020 |
Why?
|
| Prenatal Diagnosis | 2 | 1988 | 73 | 0.020 |
Why?
|
| Biomarkers | 2 | 2010 | 1593 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2798 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 448 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 211 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 413 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 344 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1988 | 21 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.020 |
Why?
|
| Reference Values | 2 | 2002 | 579 | 0.020 |
Why?
|
| Forecasting | 2 | 2002 | 277 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1987 | 70 | 0.020 |
Why?
|
| Pandemics | 1 | 2011 | 349 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1987 | 69 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1860 | 0.020 |
Why?
|
| Asthma | 1 | 2011 | 345 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1195 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 1425 | 0.020 |
Why?
|
| Fetal Blood | 2 | 1998 | 131 | 0.020 |
Why?
|
| Labor Stage, First | 1 | 1986 | 5 | 0.020 |
Why?
|
| Culture Media | 1 | 1986 | 155 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Ritodrine | 1 | 1985 | 3 | 0.020 |
Why?
|
| Apgar Score | 1 | 1985 | 22 | 0.020 |
Why?
|
| Abruptio Placentae | 1 | 2005 | 2 | 0.020 |
Why?
|
| Betamethasone | 1 | 1985 | 24 | 0.020 |
Why?
|
| Body Fluids | 1 | 1985 | 41 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1987 | 239 | 0.020 |
Why?
|
| Phospholipids | 1 | 1985 | 108 | 0.020 |
Why?
|
| Chorioamnionitis | 1 | 1985 | 40 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1986 | 284 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 121 | 0.020 |
Why?
|
| Birth Weight | 1 | 1985 | 186 | 0.020 |
Why?
|
| Echocardiography | 1 | 1987 | 515 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 567 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1986 | 339 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1985 | 951 | 0.010 |
Why?
|
| Myometrium | 1 | 1982 | 5 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1982 | 44 | 0.010 |
Why?
|
| Dinoprost | 1 | 1982 | 27 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1987 | 596 | 0.010 |
Why?
|
| Injections | 1 | 1981 | 119 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7028 | 0.010 |
Why?
|
| Pregnancy, High-Risk | 1 | 1999 | 14 | 0.010 |
Why?
|
| Heart Rate | 1 | 1981 | 568 | 0.010 |
Why?
|
| Safety | 1 | 1999 | 145 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 109 | 0.010 |
Why?
|
| Morbidity | 1 | 1999 | 130 | 0.010 |
Why?
|
| Femur | 1 | 1999 | 113 | 0.010 |
Why?
|
| Aspirin | 1 | 1999 | 295 | 0.010 |
Why?
|
| Vaginosis, Bacterial | 1 | 1998 | 24 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1549 | 0.010 |
Why?
|
| Amoxicillin | 1 | 1997 | 10 | 0.010 |
Why?
|
| Ampicillin | 1 | 1997 | 17 | 0.010 |
Why?
|
| Erythromycin | 1 | 1997 | 13 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 58 | 0.010 |
Why?
|
| Streptococcus agalactiae | 1 | 1997 | 26 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1997 | 53 | 0.010 |
Why?
|
| Carrier State | 1 | 1997 | 39 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1999 | 714 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1997 | 306 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 791 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1999 | 1329 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1996 | 737 | 0.010 |
Why?
|
| Male | 2 | 1981 | 37283 | 0.010 |
Why?
|
| Platelet Count | 1 | 1986 | 100 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1986 | 122 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 156 | 0.000 |
Why?
|
| Risk | 1 | 1986 | 563 | 0.000 |
Why?
|
| Body Weight | 1 | 1986 | 554 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1986 | 1449 | 0.000 |
Why?
|